Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer

Vivek Roy, Edith A. Perez

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences